Product Overview
Peptide Mapping protein testing, adoptProteases protein, use LC-MS/MStesting, protein protein amino acid sequence, proteindrug (CQA) throughPeptide Mapping method. throughPeptide Mapping proteinN/C, proteinamino acid sequence coverage, site,. Trypsin Peptide Mapping Proteases, Proteases Peptide Mapping 100% coverage, use Trypsin Lys-C, Glu-C, Chymotrypsin Proteases method 100% coverage.
Testing Purpose
technologymethod: Peptide Mapping
Test Category:
amino acid sequence
Testing Purpose:
drug amino acid sequence activity, clinical, Proteases (Lys-C, Asp-N Glu-C), technology amino acid sequence.
Test Category:
N, C
Testing Purpose:
N drugN method., Edman N. N/C combined with,. drug cellin vivo D, C., C, N/C,., throughN/C drug quality control.
Test Category:
Testing Purpose:
protein,. throughcombined with Peptide Mapping, 100%, amino acid sequence.
Test Category:
Testing Purpose:
Peptide Mapping,,, Glycosylation, N, C. (Met) (Trp),. drug, CDR (Asn), Asn (Gly) (NG),, CDR, combined with,.
Test Category:
N/O-Glycosylation(intact glycopeptide)
Testing Purpose:
Glycosylation drug. N "Asn X Ser/Thr"(X Pro) Asnsite; O, protein Ser Thr. Glycosylation activity,, CDC, ADCC ADCP; Glycosylation, α1,3 NGNA,, drug.
Test Category:
Disulfide Bond Analysis
Testing Purpose:
Disulfide Bond Analysis drug,. through drug,, drug quality control. Disulfide Bond Analysis,,.
Analysis Workflow
Peptide MappingAnalysis Workflow
Main Deliverables
LC-MS/MSPeptide Mapping
Peptide Mapping amino acid sequence 
N
| Protein | Residue # | Modification sites | Category | Sequence | %Abundance |
|---|---|---|---|---|---|
| HC | 55 | N55+Deamidation | Deamidation | IYPTNGYTR | 44.38 |
| HC | 318 | N318+Deamidation | Deamidation | VVSVLTVLHQDWLNGK | 26.68 |
| LC | 30 | N30+Deamidation | Deamidation | ASQDVNTAVAWYQQKPGK | 12.56 |
| HC | 387 | N387+Deamidation | Deamidation | GFYPSDIAVEWESNGQPENNYK | 7.42 |
| HC | 392 | N392+Deamidation | Deamidation | GFYPSDIAVEWESNGQPENNYK | 5.81 |
| HC | 217 | K217+Gln->Pyro-Glu | Gln->Pyro-Glu | KVEPK | 5.86 |
| HC | 374 | G374+Gln->Pyro-Glu | Gln->Pyro-Glu | GFYPSDIAVEWESNGQPENNYK | 1.46 |
| LC | 103 | K103+Glycation | Glycation | SGTDFTLTISSLQPEDFATYYCQQHY TTPPTFGQGTKVEIK | 1.1 |
| LC | 149 | K149+Glycation | Glycation | VQWKVDNALQSGNSQESVTEQDSK | 0.85 |
| HC | 329 | K329+Glycation | Glycation | VSNKALPAPIEK | 0.66 |
| HC | 255 | M255+Oxidation | Oxidation | DTLMISR | 3.67 |
| HC | 107 | M107+Oxidation | Oxidation | WGGDGFYAMDYWGQGTLVTVSSASTK | 1.88 |
| HC | 431 | M431+Oxidation | Oxidation | WQQGNVFSCSVMHEALHNHYTQK | 1.35 |
| HC | 83 | M83+Oxidation | Oxidation | NTAYLQMNSLR | 0.72 |
| LC | 4 | M4+Oxidation | Oxidation | DIQMTQSPSSLSASVGDR | 0.63 |
| HC | 39 | Q39+Gln->Pyro-Glu | Gln->Pyro-Glu | QAPGK | 3.26 |
| HC | 1 | E1-18.0106 | Gln->Pyro-Glu | EVQLVESGGGLVQPGGSLR | 3.69 |
| HC | 249 | K249+Glycation | Glycation | THTCPPCPAPELLGGPSVFLFPPKPK | 0.64 |
| HC | 300 | N300+A2G0F | N-Glycan | EEQYNSTYR | 38.42 |
| HC | 300 | N300+A2G1F | N-Glycan | EEQYNSTYR | 36.11 |
| HC | 300 | N300+A1G0F | N-Glycan | EEQYNSTYR | 9.7 |
| HC | 300 | N300+A2G2F | N-Glycan | EEQYNSTYR | 6.97 |
| HC | 300 | N300+A2G0 | N-Glycan | EEQYNSTYR | 3.37 |
| HC | 300 | N300+A1G1F | N-Glycan | EEQYNSTYR | 3.24 |
| HC | 300 | N300+A2G1 | N-Glycan | EEQYNSTYR | 1.85 |
Peptide Mapping
Shenzhen Wininnovate Bio Co., Ltd.
Innovative mass spectrometry and AI technologies provide protein and metabolite mass spectrometry multi-omics solutions for life science research, empowering the growth of the biotechnology, pharmaceutical, and healthcare industries.
